GH Research PLC (GHRS)
11.72
-0.66
(-5.33%)
USD |
NASDAQ |
May 02, 10:14
GH Research Cash from Financing (Quarterly): -0.041M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.041M |
| September 30, 2023 | -0.056M |
| June 30, 2023 | -0.037M |
| March 31, 2023 | -0.07M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2021 | -0.171M |
| September 30, 2021 | -2.602M |
| June 30, 2021 | 289.22M |
| March 31, 2021 | |
| December 31, 2020 | 5.50M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.602M
Minimum
Sep 2021
289.22M
Maximum
Jun 2021
20.84M
Average
--
Median
Jun 2020
Cash from Financing (Quarterly) Benchmarks
| Amarin Corp PLC | 0.083M |
| Jazz Pharmaceuticals PLC | -100.31M |
| Prothena Corp PLC | 0.483M |
| Iterum Therapeutics PLC | 0.589M |
| Mural Oncology PLC | -- |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.085M |
| Cash from Investing (Quarterly) | -0.024M |
| Free Cash Flow | -33.44M |
| Free Cash Flow Per Share (Quarterly) | -0.1559 |
| Free Cash Flow Yield | -5.48% |